期刊
MOLECULAR BIOLOGY REPORTS
卷 45, 期 6, 页码 2913-2923出版社
SPRINGER
DOI: 10.1007/s11033-018-4358-6
关键词
MiRNA; Pathway; Therapeutics; Clinical trials
资金
- National Natural Science Foundation of China [31502056]
- Youth Talent Development Plan of Shanghai Municipal Agricultural System [20170116]
- Young Scientist Plan of Shanghai Academy of Agricultural Sciences [ZP173]
Multidrug resistance (MDR) is still a major reason for therapeutic failure in cancers. The mechanisms underlying MDR are multifactorial and are not fully understood. miRNAs are evolutionarily conserved non-coding RNAs that function as key post-transcriptional regulators of gene expression. Emerging evidence indicates a vital role of miRNAs in the resistance to cancer treatments and suggests their potential for cancer therapy, as they can modulate multiple mechanisms link to the development of MDR. This review summarizes the recent findings on the role of miRNAs in MDR, and highlights the molecular targets and mechanisms of miRNA regulated pathways in MDR. Finally, the challenges and prospects of miRNA-targeted therapies for reversing drug resistance are reviewed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据